EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estimating optimally tailored active surveillance strategy under interval censoring

Muxuan Liang iD, Yingqi Zhao iD, Daniel W Lin, Matthew Cooperberg iD, Yingye Zheng iD

Biometrics · 2025

DOI: 10.1093/biomtc/ujaf067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrics, 2025. Verfasst von Muxuan Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of Florida, Gainesville, FL 32611, United States. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Watchful Waiting. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Active surveillance (AS) using repeated biopsies to monitor disease progression has been a popular alternative to immediate surgical intervention in cancer care. However, a biopsy procedure is invasive and sometimes leads to severe side effects of infection and bleeding. To reduce the burden of repeated surveillance biopsies, biomarker-assistant decision rules are sought to replace the fix-for-all regimen with tailored biopsy intensity for individual patients. Constructing or evaluating such decision rules is challenging. The key AS outcome is often ascertained subject to interval censoring. Furthermore, patients will discontinue participation in the AS study once they receive a positive surveillance biopsy. Thus, patient dropout is affected by the outcomes of these biopsies. This work proposes a non-parametric kernel-based method to estimate a tailored AS strategy’s true positive rates (TPRs) and true negative rates (TNRs), accounting for interval censoring and immediate dropouts. We develop a weighted classification framework based on these estimates to estimate the optimally tailored AS strategy and further incorporate the cost-benefit ratio for cost-effectiveness in medical decision-making. Theoretically, we provide a uniform generalization error bound of the derived AS strategy, accommodating all possible trade-offs between TPRs and TNRs. Simulation and application to a prostate cancer surveillance study show the superiority of the proposed method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsWatchful WaitingHumansMaleComputer SimulationDisease ProgressionBiopsyCost-Benefit AnalysisModels, StatisticalStatistics, Nonparametric

Stichwörter der Autor:innen

cancer surveillancedecision-makinggeneralization errorinterval censoringmissing data

Autor:innen und Institutionen

  • Department of Biostatistics, University of Florida, Gainesville, FL 32611, United States.
  • Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.
  • Department of Urology, University of Washington, Seattle, WA 98195, United States.
  • Epidemiology & Biostatistics, University of California, San Francisco, CA 94143, United States.

ORCID-Profile: Muxuan Liang, Yingqi Zhao, Matthew Cooperberg, Yingye Zheng

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Liang, M., Zhao, Y., Lin, D. W., Cooperberg, M., & Zheng, Y. (2025). Estimating optimally tailored active surveillance strategy under interval censoring. Biometrics. https://doi.org/10.1093/biomtc/ujaf067

Vancouver

Liang M, Zhao Y, Lin DW, Cooperberg M, Zheng Y. Estimating optimally tailored active surveillance strategy under interval censoring. Biometrics. 2025. doi:10.1093/biomtc/ujaf067

BibTeX
@article{Liang2025,
  author = {Liang, Muxuan and Zhao, Yingqi and Lin, Daniel W and Cooperberg, Matthew and Zheng, Yingye},
  title = {Estimating optimally tailored active surveillance strategy under interval censoring},
  journal = {Biometrics},
  year = {2025},
  doi = {10.1093/biomtc/ujaf067}
}
Kostenlos starten →